Calypte Biomedical Corporation develops in vitro testing products to improve the diagnosis of Human Immunodeficiency Virus (HIV) infection, STD's and other chronic diseases. Their product line includes both point-of-case rapid tests and traditional ELISA/EIA diagnostic tests.